Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-11-25

Clinical Trial Update: Individualized Treatment Strategy for Patients With Metastatic Non-clear Cell Renal Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating an individualized treatment strategy for patients with metastatic non-clear cell renal cell carcinoma is ongoing, status currently unkn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Herlev and Gentofte Hospital | Conditions: Metastatic Renal Cell Carcinoma, Kidney Neoplasm | Phase 2 | Status: UNKNOWN